Engineered exosomes: a potential therapeutic strategy for septic cardiomyopathy.

MLA

Mao, Lixia, et al. “Engineered Exosomes: A Potential Therapeutic Strategy for Septic Cardiomyopathy.” Frontiers in Cardiovascular Medicine, vol. 11, June 2024, p. 1399738. EBSCOhost, https://doi.org/10.3389/fcvm.2024.1399738.

APA

Mao, L., Liu, S., Chen, Y., Huang, H., Ding, F., & Deng, L. (2024). Engineered exosomes: a potential therapeutic strategy for septic cardiomyopathy. Frontiers in Cardiovascular Medicine, 11, 1399738. https://doi.org/10.3389/fcvm.2024.1399738

Chicago

Mao, Lixia, Songtao Liu, Yongxia Chen, Huiyi Huang, Fenghua Ding, and Liehua Deng. 2024. “Engineered Exosomes: A Potential Therapeutic Strategy for Septic Cardiomyopathy.” Frontiers in Cardiovascular Medicine 11 (June): 1399738. doi:10.3389/fcvm.2024.1399738.